Document is current
Any future updates will be listed below
-
Authors
Vos, Miriam B. https://orcid.org/0000-0002-0817-7068
Jin, Ran
Konomi, Juna V.
Cleeton, Rebecca
Cruz, Jessica
Karpen, Saul
Rodriguez, Dellys Soler
Frediani, Jennifer K.
McCracken, Courtney
Welsh, Jean
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R03 DK096157)
- License Information
-
More Information
Article History
Received: 28 February 2018
Accepted: 25 May 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: The study was approved by Emory University Institutional Review Board and by Children’s Healthcare of Atlanta Review Board prior to initiation.
: Is contained within the IRB approval.
: Dr. Vos receives grant funding and industry consulting in the area of pediatric NAFLD as follows: Dr. Miriam Vos receives research support from Immuron, Shire, AMRA, Resonance Health, Target PharmaSolutions, NIH and Nutrition Science Initiative (NuSI) and consults for Intercept, Allergan, Aegerion, Shire, Immuron, Target PharmaSolutions. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
